Skip to content
Psychedelics and Empathy | Rob Malenka episode artwork

Jan 26, 2023 18 min

Psychedelics and Empathy | Rob Malenka

from From Our Neurons to Yours Hosted by Wu Tsai Neurosciences Institute, Nicholas Weiler, Robert Malenka

Why are psychiatrists taking a fresh look at MDMA? Recently, there's been growing excitement in the scientific community about revisiting the potential medical benefits of psychedelic drugs that have been off limits for decades. Scientists are discovering or rediscovering applications of psilocybin, LSD, MDMA, and other compounds for treating people with depression, anxiety, and post-traumatic stress disorder. The Wu Tsai Neurosciences Institute has several leading experts paving the way in this field, including today's guest, Robert Malenka. Beginning in the 1980s, Malenka pioneered neuroscientists' understanding of how our brain circuits to change with experience by uncovering fundamental mechanisms of synaptic plasticity. More recently, his laboratory at Stanford has explored the brain's so-called "reward circuitry," including its role in social behavior and empathy and its response to drugs such as MDMA. Malenka is Nancy Friend Pritzker Professor of Psychiatry and Behavioral Sciences at Stanford and a Deputy Director of the Wu Tsai Neurosciences Institute where he co-directs the NeuroChoice Initiative, which takes an interdisciplinary approach to understanding human decision making and the science of addiction. Links Heifets & Malenka, "MDMA as a Probe and Treatment for Social Behaviors." Cell (2016) Heifets, et al., "Distinct neural mechanisms for the prosocial and rewarding properties of MDMA." Science Translational Medicine (2019) Multidisciplinary Association for Psychedelic Studies (MAPS) Wu Tsai Neurosciences Institute NeuroChoice Initiative More on Malenka's work "5 Questions: Robert Malenka on Ecstasy research" (Stanford Medicine, 2016) "Being a Neuroscientist: A conversation with veteran Stanford brain researcher Rob Malenka" (Stanford Medicine Scope Blog, 2018) "Social aversion during opioid withdrawal reflects blocked serotonin cues, mouse study finds" (Wu Tsai Neurosciences Institute, 2022) Episode Credits This episode was produced by Michael Osborne, with production assistance by Morgan Honaker and Christian Haigis, and hosted by Nicholas Weiler. Cover art by Aimee Garza. Send us a text! Thanks for listening! If you're enjoying our show, please take a moment to give us a review on your podcast app of choice and share this episode with your friends. That's how we grow as a show and bring the stories of the frontiers of neuroscience to a wider audience. We want to hear from your neurons! Email us at at [email protected] Learn more about the Wu Tsai Neurosciences Institute at Stanford and follow us on Twitter, Facebook, and LinkedIn.

Episode details come from the podcast's RSS feed.

Embed this episode

Why are psychiatrists taking a fresh look at MDMA? Recently, there's been growing excitement in the scientific community about revisiting the potential medical benefits of psychedelic drugs that have been off limits for decades. Scientists are discovering or rediscovering applications of psilocybin, LSD, MDMA, and other compounds for treating people with depression, anxiety, and post-traumatic stress disorder. The Wu Tsai Neurosciences Institute has several leading experts paving the way in...

Ready to play

Psychedelics and Empathy | Rob Malenka

0:00 18:42

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of From Our Neurons to Yours?

This episode is 18 minutes long.

When was this From Our Neurons to Yours episode published?

This episode was published on January 26, 2023.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this From Our Neurons to Yours episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.